NEW YORK, September 21, 2016 /PRNewswire/ --
Today, Stock-Callers reviews the performance of these services stocks: HERC Holdings Inc. (NYSE: HRI), Myriad Genetics Inc. (NASDAQ: MYGN), Qiagen NV (NASDAQ: QGEN), and INC Research Holdings Inc. (NASDAQ: INCR). At the close of Tuesday's trading session, the NASDAQ Composite ended the trading session at 5,241.35, up 0.12%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,129.96; and the S&P 500 closed at 2,139.76, up 0.03%. Learn more about these stocks by accessing their free research reports at:
Estero, Florida headquartered HERC Holdings' stock declined 2.74%, to close the day at $32.62. The stock recorded a trading volume of 479,347 shares. Shares of the Company, which engages in the rental and lease of cars and trucks worldwide, are trading 2.90% above its 200-day moving average. Additionally, the stock traded at a PE ratio of 15.12 and has a Relative Strength Index (RSI) of 40.28. Free research report on HRI is available at:
Salt Lake City, Utah headquartered Myriad Genetics Inc.'s stock finished Tuesday's session 0.53% lower at $20.76 with a total volume of 1.56 million shares traded. Shares of the Company, which focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide, are trading below its 50-day and 200-day moving averages by 18.70% and 39.10%, respectively. Myriad Genetics' stock traded at a PE ratio of 12.18 and has an RSI of 36.16. The complimentary research report on MYGN can be downloaded at:
On Tuesday, shares in Venlo, the Netherlands headquartered Qiagen N.V. ended the session 0.11% higher at $26.19 with a total volume of 844,491 shares traded. Shares of Qiagen, which provides sample to insight solutions that transform biological samples into valuable molecular insights worldwide, have gained 22.44% in the past three months. Shares of the company traded at a PE ratio of 52.48. The stock is trading 2.28% above its 50-day moving average and 11.68% above its 200-day moving average. Moreover, shares of the Company have an RSI of 51.38. Visit us today and access our complete research report on QGEN at:
INC Research Holdings
On Tuesday, shares in Raleigh, North Carolina headquartered INC Research Holdings Inc. recorded a trading volume of 369,782 shares. The stock ended the day 0.28% higher at $43.16. Shares of the Company traded at a PE ratio of 21.29. INC Research Holdings Inc.'s stock has gained 11.35% in the past three months. The Company is trading below its 50-day and 200-day moving averages by 1.21% and 0.14%, respectively. Furthermore, shares of INC Research Holdings, which provides various clinical development services for the biopharmaceutical and medical device industries, have an RSI of 46.80. Get free access to your research report on INCR at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA